default author photo

Yongping Yu

Zhejiang University - College of Pharmaceutical Sciences

China

SCHOLARLY PAPERS

1

DOWNLOADS

46

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

High PARP-1 Expression Predicts Poor Survival in Acute Myeloid Leukemia and PARP-1 Inhibitor and Saha-Bendamustine Hybrid Inhibitor Combination Treatment Synergistically Enhances Anti-Tumor Effects

, EBioMedicine, Volume 38, December 2018, Pages 47-56, https://doi.org/10.1016/j.ebiom.2018.11.025
Number of pages: 47 Posted: 24 Sep 2018
Xia Li, Chenying Li, Jingrui Jin, Jinghan Wang, Jiansong Huang, Zhixin Ma, Xin Huang, Xiao He, Yile Zhou, Yu Xu, Mengxia Yu, Shujuan Huang, Xiao Yan, Fenglin Li, Jiajia Pan, Yungui Wang, Yongping Yu and Jie Jin
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Hangzhou First People’s Hospital, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - College of Pharmaceutical Sciences and Zhejiang University - Department of Hematology
Downloads 46 (1,133,231)

Abstract:

Loading...

PARP-1, Acute myeloid leukemia, PARP inhibitor, SAHAbendamustine hybrid